Pandemic May Push 1st Zofran MDL Bellwether To 2021

A Massachusetts federal judge told lawyers representing GlaxoSmithKline and plaintiffs who claim its anti-nausea medicine Zofran caused birth defects that he's open to creative ways to hold a complex jury trial...

Already a subscriber? Click here to view full article